This is a reply to a comment that Coyle (2020) made on our article entitled "Which valued-based price when patients are heterogeneous?" (Levaggi and Pertile, 2020).
A reply to "Who would benefit from average value-based pricing?"
Paolo Pertile
2021-01-01
Abstract
This is a reply to a comment that Coyle (2020) made on our article entitled "Which valued-based price when patients are heterogeneous?" (Levaggi and Pertile, 2020).
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
